SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility after a parabolic rally led to a massive, swift decline, sparking widespread debate about whether the project is a legitimate effort or a sophisticated pump-and-dump scheme. Community members are actively scrutinizing the team's token distribution and recent statements regarding market manipulation, while traders remain divided between those attempting to buy the dip for a potential bounce and those warning of a total collapse.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is currently showing signs of consolidation around key support levels as the market balances geopolitical uncertainty with ongoing institutional accumulation. Traders are actively debating whether recent stability and infrastructure updates will serve as the necessary catalyst for a potential upward expansion.

Asteroid Shiba is inspired by a real-life event where a Shiba Inu plush toy named "Asteroid" served as a zero-gravity indicator during the Polaris Dawn mission. This connection to space travel gives it a narrative that's both whimsical and grounded in a tangible event, differentiating it from other meme coins which might rely solely on internet culture or celebrity endorsements.  The coin's mascot, the zero-gravity Shiba Inu, was designed by a young cancer survivor, Liv Perrotto, adding a layer of emotional connection and human interest story that's rare in the crypto space. This backstory not only provides a unique selling point but also a community rallying point.

Asteroid Shiba

Asteroid Shiba is capturing significant community attention as a high-volatility memecoin experiencing rapid price movement, fueling intense debate over whether it represents a sustainable breakout or a classic pump-and-dump scenario. Traders are actively comparing its trajectory to other speculative assets while speculating on its potential for wider exchange listings and future market viability.

What Is Request (REQ)? The Request (REQ) utility token, launched in 2017, ensures the performance and stability of the Request Network. The Request Network itself is an Ethereum-based decentralized payment system where anyone can request a payment and receive money through secure means. It removes the requirement for third parties in order to provide a cheaper, more secure payment solution that works with all global currencies.  When a user creates a request for payment, they define to which address the payment needs to be allocated and what the amount is. The user can also define the terms and conditions of the payment, upgrading a simple request into an invoice. Once this is completed, the user can share their request to be paid by their counterparty.  Every step is documented and stored on the Request network, allowing everyone involved to easily keep track of all the invoices and payments for accounting purposes.  Request is also integrated with legislation across the world to remain compliant with the trade laws of each individual country.  Who Are the Founders of Request? The founders of Request are Christophe Lassuyt and Etienne Tatur.  Christophe Lassuyt is currently the chief financial officer at Request. Before this position, he co-founded MONEYTIS.  Etienne Tatur is the chief technical officer of Request. Prior to this, he also co-founded MONEYTIS and worked as a lead developer at QOBUZ, a music streaming service.  What Makes Request Unique? The payments on Request are performed by simply sending an invoice through the blockchain; the counterparty can then detect the request and pay it with one click in a peer-to-peer manner. The fact that the payments are push-generated instead of pull-generated is one of Request’s key advantages. There is no need for users to share their account information. The use of blockchain technology also eliminates the need for third-party processors, resulting in a reduction in transaction costs.  The Request Network leverages decentralized blockchains such as Ethereum and IPFS for an increased level of security, privacy and data ownership for the end-user. The platform does have transaction fees, which is a cost that is required to broadcast a change to the blockchain network. The transaction fees are used to incentivize miners to reach consensus on the state of the network.  REQ can be stored on wallets such as Metamask, MyEtherWallet, Ledger, imToken, Trezor, Atomic Wallet, Jaxx Liberty and Trust Wallet.  How Many Request (REQ) Coins Are There in Circulation? REQ is an ERC-20 token that can be spent to use the Request Network.  A portion of the REQ fee is burned at a rate that is determined by the current supply and the exchange rate with other currencies.  Request’s (REQ) circulating supply is at 999,912,165 REQ as of February 2021 and the maximum supply is 999,983,984 tokens.  How Is the Request Network Secured? REQ is an ERC-20 token based on the Ethereum platform. The requests made with REQ are stored on an immutable digital ledger. This ledger also serves as proof for all auditing purposes.

Request Network

Request Network is trending as the community speculates on a potential repeat of previous parabolic holiday runs, fueled by active accumulation and recent news regarding the acquisition of Payso. Despite frustration among long-term holders over stagnant price action and communication gaps, discussions remain polarized between those aggressively buying the consolidation and skeptics calling for caution due to thin liquidity.

About Bancor? Bancor is an ecosystem of decentralized, open-source protocols that promote on-chain trading and liquidity.   Its main protocol, Carbon, is a decentralized trading protocol allowing users to perform automated trading strategies using custom on-chain limit orders and range orders, with the option of combining orders together to create automated buy low, sell high strategies.   Fast Lane, a separate open-source arbitrage protocol, allows any user to perform arbitrage between Bancor ecosystem protocols and external on-chain exchanges and redirect arbitrage profits back to the Bancor ecosystem.  All Bancor ecosystem protocols are governed by the BancorDAO via staked BNT.  What makes Bancor Unique? Bancor’s flagship protocol, Carbon, allows users to perform automated trading strategies on-chain with far greater control and efficiency compared to existing decentralized exchanges (DEXs).  Existing on-chain liquidity solutions suffer from key drawbacks, namely that: 1) executed orders can be reversed when prices move, and 2) a single liquidity position must execute both buys and sells using the same pricing curve. As a result, on-chain liquidity is costly and complex to automate and update, while exposing traders to MEV sandwich attacks.  Carbon introduces a new form of on-chain liquidity called Asymmetric Liquidity, which allows users to create individual liquidity positions with two distinct pricing curves: one for buying and one for selling. This gives users the ability to set buy and sell orders that execute in specific price ranges, with the option of combining orders together to create automated buy low, sell high strategies. By design, Carbon orders are irreversible on execution, easily adjustable directly on-chain, and completely resistant to MEV sandwich attacks. These capabilities give users an unprecedented level of control and automation to perform novel trading strategies on-chain.  For example, a user who believes ETH will trade in the near future between $1500-2000 could set a Carbon strategy that automatically buys ETH between $1500-1600 and sells the ETH from $1900-2000. As market prices move into selected ranges, orders are automatically executed by traders who interact with Carbon directly, or via popular DEX aggregators. All with no reliance on external oracles or keepers. Strategy updates can be made in a highly gas efficient manner, without needing to withdraw and re-add liquidity, via parameters in a strategy’s smart contract.  Carbon also improves on the trading model in centralized exchanges by allowing users to create multi-order strategies that utilize a single source of rotating liquidity to fill trades, eliminating the need to create multiple limit orders and pre-fund each order as it is created. By fusing the feature-rich trading functionality of centralized exchanges with the access and transparency of automated market-makers, Carbon unlocks the future of decentralized on-chain trading.  History of Bancor Bancor invented the first blockchain-based automated market maker (AMM) in 2017. The protocol’s first version was launched in June 2017, with subsequent protocol versions iterating on the original AMM model.  In 2020, the BancorDAO was launched to oversee and govern development of Bancor ecosystem protocols. The BancorDAO has since voted on over 450 governance proposals, and has had at the time writing over 9,700 governance token holders, and over 1,100 voters.  What’s Next for Bancor Per the BancorDAO, the Bancor community is focused on development of its flagship protocols, Carbon and Fast Lane. The beta version of Fast Lane is currently live on Ethereum mainnet, and will continue evolving, while the beta version of Carbon is expected to go live on Ethereum mainnet in the second quarter of 2023, pending voting by the BancorDAO. From there, deployment of both Carbon and Fast Lane on other Layer-1 and Layer-2 blockchains will be explored.   The Bancor community will continue executing on its mission to build innovative solutions that expand the design space for on-chain trading and liquidity and open the doors to a wide range of future DeFi applications and products.  What Can Bancor (BNT) Be Used For The Bancor Network Token (BNT) can currently be staked for vBNT to vote in BancorDAO governance, with additional BNT utility controlled by the BancorDAO.  Relevant Sources:  Bancor Github Carbon Website Introducing Carbon Blog Post Fast Lane Carbon Whitepaper Carbon Litepaper

Bancor

Bancor is trending as the community highlights its recent integrations of Carbon DeFi across multiple chains and the continued expansion of its Arb Fast Lane infrastructure. Traders are actively discussing the protocol's pivot toward specialized DeFi tools, alongside ongoing legal and competitive debates regarding its automated market maker technology.

ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

ICU Medical, Inc.

ICU Medical is currently in the spotlight as investors track the company's efforts to integrate the Smith Medical acquisition while weighing its long-term potential for market share gains. The community is actively debating the stock's valuation, recent management moves, and the impact of broader supply chain and regulatory pressures on future growth.

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DaVita Inc

DaVita is currently under scrutiny as community members discuss the potential impact of new GLP-1 treatments on long-term dialysis patient outcomes, while simultaneously highlighting a significant gap in care quality regarding the adoption of infection-prevention tools like DefenCath. Investors are also closely monitoring for potential strategic partnerships and the broader implications of recent legislative kidney care proposals on the company's future operational landscape.

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG - ADR

Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care is trending as the community highlights its strategic adoption of DefenCath, a catheter lock solution shown to significantly reduce bloodstream infections in dialysis patients, contrasting with DaVitas lack of widespread implementation. Investors are actively discussing the potential financial and patient-outcome impacts of this antimicrobial initiative as it integrates into Freseniuss broader operational efficiency and quality improvement efforts.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

401JK is trending due to its unique "Resist and Retire" narrative, which leverages community-driven memes to challenge traditional and often rigged retirement systems. Investors are actively discussing its strong grassroots movement, regular IRL raids, and educational initiatives that distinguish it from standard speculative tokens in a challenging market environment.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is surging as the community celebrates a massive Q3 beat, driven by strong robotic procedure volumes and raised full-year growth guidance. Investors are actively discussing the stock's impressive rebound from recent lows, with many viewing the da Vinci 5 platform rollout and ongoing procedure growth as clear signals of long-term dominance.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Will Keytruda Continue to Aid Merck's Top Line in Q1 Earnings?

MRK's Keytruda, driving over half of its pharma sales, remains in focus as Q1 nears, with growth expected from new indications and strong uptake.

<ul class="summary-bullets"><li>C4&nbsp;Therapeutics is also eligible to earn tiered royalties on future product sales.</li><li>C4 and Roche will focus on developing emerging cancer treatments using degrader-antibody conjugates and targeted protein degradation processes.</li><li>The companies will work together on two programs to develop the new cancer treatments.&nbsp;</li></ul>Shares of C4 Therapeutics, Inc. (CCCC) reversed pre-market gains to edge 2% lower on Thursday, after the company expanded its partnership with Swiss pharmaceutical company Roche to develop cancer treatments.C4 Therapeutics said the new collaboration will focus on developing emerging cancer treatments using&nbsp;a degrader-antibody conjugate (DAC) and targeted protein degradation (TPD) processes.&nbsp;“Our new collaboration leverages C4T’s ability to design highly catalytic and selective degraders, as well as degrader payloads for DACs, alongside Roche’s extensive experience developing ADCs with specific binding. Together, these capabilities build a powerful new modality that can offer transformative medicines for patients,” said Andrew Hirsch, President and CEO of C4 Therapeutics.<h2 class="st-heading-2">C4 Could Earn Up To $1 Billion</h2>The companies will work together on two programs to develop new cancer treatments. C4&nbsp;Therapeutics&nbsp;will design the drug components using its TORPEDO platform, which uses advanced tools and AI to target harmful proteins.&nbsp;&nbsp;Roche will create the antibodies and combine them with the drug. Roche will also handle testing, development, and sales.&nbsp;C4&nbsp;Therapeutics&nbsp;will receive a $20 million upfront payment for the two programs, with the potential for additional payments if Roche opts to include a third target. The agreement also includes near-term discovery milestones, while total milestone payments could exceed $1 billion. Additionally, the firm is eligible to earn tiered royalties on future product sales.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Despite the reversal after the opening bell, retail sentiment on Stocktwits for <a href="https://stocktwits.com/symbol/CCCC">CCCC</a> flipped to ‘extremely bullish’ from&nbsp; ‘bearish’ a day earlier, amid ‘high’ message volumes.One user said that, based on the contract, the stock should be around $4 to $5. It is currently around $2.8.<stembedurl>https://stocktwits.com/intrader/message/649802478</stembedurl>Another bullish user highlighted the company’s runway until 2028.<stembedurl>https://stocktwits.com/intrader/message/649810594</stembedurl>The stock has shot up more than 35% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

CCCC Stock Reverses Pre-Market Gains After Roche Tie-Up To Develop Cancer Treatments - Retail Sees Strong Upside

Under the agreement, C4 Therapeutics will receive a $20 million upfront payment and could earn over $1 billion in milestone payments.

Equity

Regeneron Wins FDA Nod for Extended Eylea HD Dosing Interval

REGN wins FDA nod to extend Eylea HD dosing to 20 weeks, boosting flexibility for wAMD and DME patients while reinforcing its push to offset declining Eylea sales.

SRRK Stock Jumps on Resubmission of FDA Filing for SMA Drug

Scholar Rock stock jumps 14% after it resubmits its FDA filing for SMA drug apitegromab, revives approval hopes and sets up a potential September 2026 decision.

Biogen Secures FDA Nod for Higher Dose of SMA Drug Spinraza

BIIB gains after the FDA clears higher-dose Spinraza, with data showing improved motor function and potential to counter rising SMA competition.

The Zacks Analyst Blog  Roche Holding, AT&T and Amgen 

AMGN, T, and Roche shares outperform as strong drug portfolios and wireless momentum offset key headwinds like pricing pressure and legacy declines.

Top Stock Reports for Roche, AT&T & Amgen

Roche's strong drug growth is offsetting legacy declines, while strategic deals aim to reshape its portfolio amid biosimilar pressure and FX headwinds.

AZN Stock Gains as COPD Drug Clears Two Late-Stage Studies

AstraZeneca jumps as tozorakimab hits primary goals in two phase III COPD trials, cuts exacerbations and shows promise in a disease with limited options.

REGN Soars 28.9% in Six Months: Is There More Upside Potential in 2026?

Regeneron's rally reflects biotech momentum as pipeline wins and Dupixent growth offset Eylea erosion amid intensifying competition.

Can Anktiva's Label Expansion Unlock the Next Growth Phase for IBRX?

ImmunityBio bets on Anktiva label expansion to drive growth, but intense Big Pharma competition and premium valuation raise questions about its next phase.

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

RHHBY
Roche Holdings AG ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RHHBY News

RHHBYRoche Holdings AG ADR